Literature DB >> 26762535

Psychosocial and respiratory disease related to severe bladder dysfunction and non-monosymptomatic enuresis.

Lisieux Eyer de Jesus1, Alberto Tomé2, Diego Cobe2, Pedro Camelier2.   

Abstract

OBJECTIVE: Complicated bladder dysfunctions (BD) (associated with infections/urological complications or irresponsive to treatment) are a small proportion of all cases, but are highly morbid, clinically and psychosocially. Our aim is to describe a cohort of complicated pediatric BD, using subgroup analysis to compare presentations and responses to treatment among genders, age groups, and patients with or without non-monosymptomatic enuresis (NME). We also relate severe BD to other health conditions or to social/behavioral problems and report treatment results.
METHOD: Thirty-five cases of complicated BD were reviewed. Neurogenic bladders and anatomical urological problems were excluded. Justifications for referral, comorbidities, and social aspects/familial dynamics were studied. Overactive bladders were primarily treated with oxybutynin. Transcutaneous parasacral neuromodulation was used in case of insufficient response or unbearable side effects. For infrequent voiders, timed voiding and transcutaneous neuromodulation were counseled.
RESULTS: Incontinence/enuresis were the motives for referral in only a third of the cases. UTI (42.9%) was the main reason for referral. Hydronephrosis was observed in 8.6% of the children. Respiratory/ENT problems, obesity, and precocious puberty were highly prevalent. Schooling problems and neuropsychiatric disease were common. Social problems were common. Five patients presented urological problems secondary to BD (hydroureteronephrosis, VUR, trabeculated bladder). Twenty percent of cases required high anticholinergic doses and 37.1% transcutaneous electrostimulation. Eight (22.9%) patients abandoned but later resumed therapy, and 14.6% did not follow treatment. Boys tended to be older than girls and presented NME, respiratory, and behavioral problems more often, with a significant difference for asthma and anxiety/depression. Associated health problems and neuropsychiatric treatment tended to be more frequent among those presenting NME. Non-enuretic children tended to show better results from treatment (see Table).
CONCLUSION: The social characteristics of our population (severe cases, socially deprived, very poor, not well educated, and with limited access to health care) determine a very specific sampling. Our research demonstrated that even severe cases of BD affecting socially deprived children may be treated, with adhesion to treatment and results comparable with other cohorts of BD, although the children need multidisciplinary attention and close follow-up. Boys, older children, and NME are more difficult to treat and often have other associated health and behavioral problems. Stress-related conditions were common in severe BD. A relatively high occurrence of precocious puberty was an unexpected finding in our research.
Copyright © 2016 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bladder dysfunction; Comorbidities; Pediatric; Polysymptomatic enuresis

Mesh:

Year:  2015        PMID: 26762535     DOI: 10.1016/j.jpurol.2015.11.012

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  3 in total

1.  Association between allergic disease, sleep-disordered breathing, and childhood nocturnal enuresis: a population-based case-control study.

Authors:  Jeng-Dau Tsai; Hsuan-Ju Chen; Min-Sho Ku; Shan-Ming Chen; Chih-Chuan Hsu; Min-Che Tung; Che-Chen Lin; Hsing-Yi Chang; Ji-Nan Sheu
Journal:  Pediatr Nephrol       Date:  2017-07-22       Impact factor: 3.714

2.  Incontinence in autism spectrum disorder: a systematic review.

Authors:  Justine Niemczyk; C Wagner; A von Gontard
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-10       Impact factor: 4.785

3.  Enuresis Nocturna in children with asthma: prevalence and associated risk factors.

Authors:  Emin Ozkaya; Seren Calıs Aydın; Mebrure Yazıcı; Rusen Dundaröz
Journal:  Ital J Pediatr       Date:  2016-06-10       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.